High cost drugs in Latin America: access and barriers
D Rosselli - Expert Review of Pharmacoeconomics & Outcomes …, 2023 - Taylor & Francis
ABSTRACT Introduction Latin America comprises a large set of culturally diverse middle-
income countries sharing an inequality gap and a rapidly aging population. A better …
income countries sharing an inequality gap and a rapidly aging population. A better …
[图书][B] Healthcare rights on trial in Latin America: A comparative study
RG Silva - 2024 - books.google.com
A muchos pacientes se les niega el acceso a los servicios de salud ya los medicamentos en
América Latina, por lo que los jueces tienen que intervenir. Esta tendencia de …
América Latina, por lo que los jueces tienen que intervenir. Esta tendencia de …
Regulated pricing decisions and diagnostic test choices in personalized medicine: Navigating the implications within legal frameworks
Z Cui, X Liu, Z Feng, Z Huang - 2024 - researchsquare.com
Background: This study investigates the interplay between the government's regulated
pricing decisions and drug manufacturers' diagnostic test choices in personalized medicine …
pricing decisions and drug manufacturers' diagnostic test choices in personalized medicine …
Financial impact on social security of the incorporation of adalimumab for the treatment of hidradenitis suppurativa: An analysis of the 61-million-contributor Brazilian …
LFV d'Almeida, ACB de Oliveira… - Journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Financial impact on social security of the incorporation of adalimumab for the treatment of
hidradenitis suppurativa: An analysis of the 61-million-contributor Brazilian Social Security …
hidradenitis suppurativa: An analysis of the 61-million-contributor Brazilian Social Security …
Cannabidiol para la epilepsia resistente a fármacos en Argentina: evaluación de tecnología sanitaria
S Hasdeu, J Álvarez, C Milone… - Revista Argentina de …, 2022 - SciELO Argentina
CANNABIDIOL PARA LA EPILEPSIA RESISTENTE A FÁRMACOS EN ARGENTINA:
EVALUACIÓN DE TECNOLOGÍA SANITARIA Page 1 CANNABIDIOL PARA LA EPILEPSIA …
EVALUACIÓN DE TECNOLOGÍA SANITARIA Page 1 CANNABIDIOL PARA LA EPILEPSIA …
[PDF][PDF] Beyond the transnational: exploring organisational complexity and innovation in biopharmaceutical firms
S Macro - 2020 - repository.lboro.ac.uk
This phenomenon of interest is investigated with a qualitative study based on company
cases studies combined with interviews with senior directors in biopharmaceutical MNEs. A …
cases studies combined with interviews with senior directors in biopharmaceutical MNEs. A …
Methodological quality of economic assessments of antineoplastics submitted to Supplementary Health Agency in the update of the 2020 list--Critical assessment …
AM Bagattini, DV Pachito, RL Pacheco… - Jornal Brasileiro de …, 2021 - go.gale.com
Objective: To describe and critically appraise the economic evaluations of antineoplastic
drugs submitted to the ANS during the process of updating its 2020'list of procedures …
drugs submitted to the ANS during the process of updating its 2020'list of procedures …